BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23322906)

  • 1. A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.
    Warner N; Burberry A; Franchi L; Kim YG; McDonald C; Sartor MA; Núñez G
    Sci Signal; 2013 Jan; 6(258):rs3. PubMed ID: 23322906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion.
    Warner N; Burberry A; Pliakas M; McDonald C; Núñez G
    J Biol Chem; 2014 Oct; 289(41):28213-24. PubMed ID: 25170077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
    Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
    J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
    Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
    Front Immunol; 2022; 13():988862. PubMed ID: 36189261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Z-100, extracted from Mycobacterium tuberculosis strain Aoyama B, promotes TNF-α production via nucleotide-binding oligomerization domain containing 2 (Nod2)-dependent NF-κB activation in RAW264.7 cells.
    Katsunuma K; Yoshinaga K; Ohira Y; Eta R; Sato T; Horii T; Tanaka T; Takei M; Seto K
    Mol Immunol; 2015 Mar; 64(1):218-27. PubMed ID: 25499802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway.
    Werts C; le Bourhis L; Liu J; Magalhaes JG; Carneiro LA; Fritz JH; Stockinger S; Balloy V; Chignard M; Decker T; Philpott DJ; Ma X; Girardin SE
    Eur J Immunol; 2007 Sep; 37(9):2499-508. PubMed ID: 17705131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn disease.
    Mohanan V; Grimes CL
    J Biol Chem; 2014 Jul; 289(27):18987-98. PubMed ID: 24790089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi screening identifies mediators of NOD2 signaling: implications for spatial specificity of MDP recognition.
    Lipinski S; Grabe N; Jacobs G; Billmann-Born S; Till A; Häsler R; Aden K; Paulsen M; Arlt A; Kraemer L; Hagemann N; Erdmann KS; Schreiber S; Rosenstiel P
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21426-31. PubMed ID: 23213202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
    Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
    Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
    J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nod2 downregulates TLR2/1 mediated IL1β gene expression in mouse peritoneal macrophages.
    Dahiya Y; Pandey RK; Sodhi A
    PLoS One; 2011; 6(11):e27828. PubMed ID: 22114704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.
    Abbott DW; Yang Y; Hutti JE; Madhavarapu S; Kelliher MA; Cantley LC
    Mol Cell Biol; 2007 Sep; 27(17):6012-25. PubMed ID: 17562858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease.
    Stronati L; Negroni A; Merola P; Pannone V; Borrelli O; Cirulli M; Annese V; Cucchiara S
    Inflamm Bowel Dis; 2008 Mar; 14(3):295-302. PubMed ID: 18092345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
    Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
    Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease.
    Wang TT; Dabbas B; Laperriere D; Bitton AJ; Soualhine H; Tavera-Mendoza LE; Dionne S; Servant MJ; Bitton A; Seidman EG; Mader S; Behr MA; White JH
    J Biol Chem; 2010 Jan; 285(4):2227-31. PubMed ID: 19948723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses.
    Marinis JM; Homer CR; McDonald C; Abbott DW
    J Biol Chem; 2011 Jan; 286(3):1938-50. PubMed ID: 21097508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial function.
    Yamamoto-Furusho JK; Barnich N; Hisamatsu T; Podolsky DK
    Inflamm Bowel Dis; 2010 May; 16(5):736-42. PubMed ID: 19856414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling.
    McDonald C; Chen FF; Ollendorff V; Ogura Y; Marchetto S; Lécine P; Borg JP; Nuñez G
    J Biol Chem; 2005 Dec; 280(48):40301-9. PubMed ID: 16203728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis.
    Wu J; Zhang Y; Xin Z; Wu X
    Mol Immunol; 2015 Apr; 64(2):235-43. PubMed ID: 25549945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
    Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
    Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.